Session 7
Ongoing clinical trials and recent results

Programme

• 09:00 – 09:12 9 Min. 3 Min.

  • Oral Presentation
  • OP-29

  Hyperthermia clinicals trials in Catalan Institute of Oncology: Initial results

  • Dr. Marina Arangüena Peñacoba (Barcelona / ES)

   Ongoing clinical trials
• 09:12 – 09:32 15 Min. 5 Min.

  • Invited Talk
  • IT-07

  The role of hyperthermia in rectal cancer: Promising results, limitations and an upcoming randomized phase 3-trial

  • Prof. Dr. Oliver J. Ott (Erlangen / DE)
• 09:32 – 09:44 9 Min. 3 Min.

  • Oral Presentation
  • OP-30

  Interim results of the european registry study for the treatment of recurrent glioblastoma (2019-2023) using the NanoTherm Therapy System (NTTS)

  • Dr. Andreas Jordan (Berlin / DE)

   Hyperthermia clinical applications: radio-chemo-immunotherapy
• 09:44 – 09:56 9 Min. 3 Min.

  • Oral Presentation
  • OP-31

  A pilot study of chemoimmunotherapy combined with deep hyperthermia and spatially-fractionated radiotherapy in advanced biliary tract cancer

  • Jason Molitoris (Baltimore / US)

   Ongoing clinical trials
• 09:56 – 10:08 9 Min. 3 Min.

  • Oral Presentation
  • OP-32

  A randomized phase III trial comparing trabectedin to trabectedin combined with regional hyperthermia in patients with pre-treated soft tissue sarcoma: HyperTET a German Interdisciplinary Sarcoma Group (GISG) trial

  • Gesa Schuebbe (Munich / DE)

   Hyperthermia clinical applications: radio-chemo-immunotherapy
• 10:08 – 10:10 2 Min. 0 Min.

  • Flash Presentation
  • FP-30

  Neoadjuvant concurrent gemcitabine and radiotherapy for soft tissuesarcoma: Assessment of toxicity and efficacy

  • Dr. Pasquale Trecca (Rome / IT)

   Ongoing clinical trials